Auriga downgraded Allscripts-Misys Healthcare (NASDAQ: MDRX) from Buy to Hold saying they see limited upside to their new $24 price ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE